These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 12436444)

  • 61. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
    Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Results of a randomized polychemotherapy study in malignant melanoma].
    Fiedler H; Hetschko I; Wohlrab W; Wozniak KD; Lübbe D; Taube KM
    Hautarzt; 1990 Jul; 41(7):369-74. PubMed ID: 1698185
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
    Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
    Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
    Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.
    Hwu WJ; Knight RD; Patnana M; Bassett R; Papadopoulos NE; Kim KB; Hwu P; Bedikian A
    Melanoma Res; 2010 Dec; 20(6):501-6. PubMed ID: 20859231
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
    De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
    Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Cheung T; Holland JF
    Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
    [No Abstract]   [Full Text] [Related]  

  • 68. [Chemotherapy of malignant melanoma].
    Ishihara K; Yamazaki N; Asano K
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Combination of dacarbazine, vindesine and interferon alpha in the treatment of metastatic melanoma].
    Mansat-Krzyzanowska E; Dreno B
    Ann Dermatol Venereol; 1994; 121(12):884-7. PubMed ID: 7632005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low-dose continuous chemotherapy for metastatic melanoma: a phase II trial.
    Nystrom ML; Steele JP; Shamash J; Neville F; Oliver RT
    Melanoma Res; 2003 Apr; 13(2):197-9. PubMed ID: 12690305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma.
    Vuoristo MS
    Melanoma Res; 1996 Aug; 6(4):331-6. PubMed ID: 8873054
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.
    Cocconi G; Bella M; Calabresi F; Tonato M; Canaletti R; Boni C; Buzzi F; Ceci G; Corgna E; Costa P
    N Engl J Med; 1992 Aug; 327(8):516-23. PubMed ID: 1635566
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
    Deutschbein T; Matuszczyk A; Moeller LC; Unger N; Yuece A; Lahner H; Mann K; Petersenn S
    Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):540-3. PubMed ID: 21667440
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
    Vuoristo M; Gröhn P; Kumpulainen E; Korpela M
    Eur J Cancer; 1994; 30A(3):420. PubMed ID: 7515632
    [No Abstract]   [Full Text] [Related]  

  • 75. Our experience with interferon alpha: metastatic malignant melanoma.
    Merimsky O; Chaitchik S
    Mol Biother; 1992 Sep; 4(3):135-8. PubMed ID: 1445667
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
    Reinhold U; Bruske T; Kreysel HW
    Eur J Cancer; 1996 Jan; 32A(1):180. PubMed ID: 8695233
    [No Abstract]   [Full Text] [Related]  

  • 77. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome.
    Schuster R; Lindner M; Wacker F; Krössin M; Bechrakis N; Foerster MH; Thiel E; Keilholz U; Schmittel A
    Melanoma Res; 2010 Jun; 20(3):191-6. PubMed ID: 20335820
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Therapeutic response of interferon-beta in malignant melanoma].
    Ishihara K
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1010-6. PubMed ID: 2421645
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
    Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
    Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
    Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
    Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.